The FDA has approved a label update for Eli Lilly’s Kisunla, an Alzheimer’s treatment, by modifying the recommended dosing schedule for adults with early symptomatic Alzheimer’s disease. The update ...

Recognizing the five critical signs of Alzheimer's final progression helps families understand what to expect and how to ...